CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)
NCT03408587
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class
Conditions
Uveal Melanoma
Liver Metastases
Interventions
BIOLOGICAL:
CVA21
BIOLOGICAL:
Ipilimumab
Sponsor
Viralytics